Levetiracetam

• 产品号: L8668
• CAS号: 102767-28-2
• 分子式: C8H14N2O2
• 分子量: 170.20896
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: Levetiracetam
• IUPAC标准名: (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
• IUPAC传统名: levetiracetam
• 别名: (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; Keppra®; 2(S)-(2-oxopyrrolidin-1-yl)butyramide

产品登记号

• CAS号: 102767-28-2
• MDL号: MFCD03265610

产品性质

• Empirical Formula (Hill Notation): C8H14N2O2
• 纯度: ≥98% (HPLC)
• 外观: white powder
• 溶解度: H2O: >5 mg/mL
• GHS警示词: Warning
• GHS危险声明: H302-H319
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 个人保护装置: dust mask type N95 (US), Eyeshields, Gloves
• GHS警示性声明: P305 + P351 + P338
• 危险公开号: 22-36
• RTECS编号: UX9656166
• 安全公开号: 26
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.

详细说明 (简体中文)

Biochem/physiol Actions
Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
法律信息
Keppra 注册商标 UCB Pharma, S.A.